-
Development of G2019S Selective LRRK2 Inhibitors for the Treatment of Parkinson’s Disease
… in models of the disease. Project Description: Researchers have recently discovered several selective LRRK2 … tolerated than inhibitors of wild-type LRRK2. Relevance to Diagnosis/Treatment of Parkinson’s Disease: … appears to be a key driver of some forms of PD, and this research aims to deliver experimental drugs that can be used …
-
Tour de Fox Crosses the Finish Line and Raises Nearly $2 Million for Research
September 17, 2015
… raised $1.87 million (and counting) for Parkinson’s research, nearly double the Tour’s original $1 million fundraising … days on the road in support of Parkinson’s research? His mother Lucy who has been living with …
-
Michael J. Fox Foundation for Parkinson’s Research to Host PD Therapeutics Conference Monday, September 15, in Chicago
August 12, 2008
… PhD, Rush University Medical Center; select MJFF-funded researchers (see partial listing below) Who Should Attend: … disease-modifying and symptomatic interventions for the diagnosis and treatment of PD. Select MJFF-funded … members of the press. A multidisciplinary audience of nearly 200 academic, pharmaceutical and biotechnology …
-
Accelerating Discovery by Developing and Distributing Research Tools with Nicole Polinski Podcast Transcript
-
Personalized Approaches for Understanding, Assessing and Improving Gait in Parkinson’s Disease Research Program
-
Promoting Diversity, Equity and Inclusion in Parkinson’s Disease (PD) Research: Clinical Disease Course and Healthcare Access in Black People with PD
… with respect to potential confounding factors. Impact on Diagnosis/Treatment of Parkinson’s Disease: This study will … Diversity, Equity and Inclusivity in Parkinson's research …